Xanthomatous pseudotumor: An unusual postchemotherapy phenomenon in breast cancer

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 6, 2003, Pages 739-741

  Tan, Kong Bing ^a   Thamboo, Thomas Paulraj ^b   Raju, Gangaraju C ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ARTICLE; ATROPHY; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CELL INFILTRATION; CELL VACUOLE; DRUG TOLERABILITY; FEMALE; FIBROSIS; FOAM CELL; FOLLOW UP; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; PARTIAL MASTECTOMY; PSEUDOTUMOR; SIDE EFFECT; TREATMENT OUTCOME; TUMOR NECROSIS; XANTHOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FEMALE; FOAM CELLS; HISTIOCYTES; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; XANTHOMATOSIS;

EID: 0037566468     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SE. Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg. 2000;190:350-363.
2. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999;17:460-469.
3. Kennedy S, Merino MJ, Swain SM, Lippman ME. The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol. 1990;21:192-198.
4. Aktepe F, Kapucuoglu N, Pak I. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology. 1996;29:63-67.
5. Honkoop AH, Pinedo HM, De Jong JS, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol. 1997;107:211-218.
6. Demaria S, Volm MD, Shapiro RL, et al. Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin Cancer Res. 2001;7:3025-3030.
7. Keurer HM, Newman LA, Buzdar AU, et al. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status [see comments]. Cancer J Sci Am. 1998;4:230-236.
8. El-Didi MH, Moneer MM, Khaled HM, Makarem S. Pathologic assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management. Surg Today. 2000;30:249-254.